Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma
Jiayuan Huang, Kai Zhang, Dongqin Chen, et al.
Oncotarget (2015) Vol. 6, Iss. 21, pp. 18613-18630
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Role of epithelial to mesenchymal transition in hepatocellular carcinoma
Gianluigi Giannelli, Petra Koudelková, Francesco Dituri, et al.
Journal of Hepatology (2016) Vol. 65, Iss. 4, pp. 798-808
Open Access | Times Cited: 535
Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs
Margherita Alba Carlotta Pomatto, Benedetta Bussolati, Sergio D’Antico, et al.
Molecular Therapy — Methods & Clinical Development (2019) Vol. 13, pp. 133-144
Open Access | Times Cited: 188
Toward the promise of microRNAs – Enhancing reproducibility and rigor in microRNA research
Kenneth W. Witwer, Marc K. Halushka
RNA Biology (2016) Vol. 13, Iss. 11, pp. 1103-1116
Open Access | Times Cited: 146
<p>miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer</p>
Hua Bai, Suhui Wu
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 11069-11082
Open Access | Times Cited: 103
Gold nanoparticles: synthesis, physiochemical properties and therapeutic applications in cancer
Xinyu Liu, Jing‐Quan Wang, Charles R. Ashby, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 5, pp. 1284-1292
Closed Access | Times Cited: 100
miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma
Emanuela Minna, Paola Romeo, Matteo Dugo, et al.
Oncotarget (2016) Vol. 7, Iss. 11, pp. 12731-12747
Open Access | Times Cited: 91
MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer
Peijun Zhang, Wenfu Tang, H Zhang, et al.
British Journal of Cancer (2017) Vol. 117, Iss. 4, pp. 525-534
Open Access | Times Cited: 89
Exosomal miRNAs in hepatocellular carcinoma development and clinical responses
Shuangshuang Li, Jiping Yao, Mingjie Xie, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 84
Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights
Nouf Juaid, Amr Amin, Ali Abdalla, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10774-10774
Open Access | Times Cited: 83
MiR-451a suppressing BAP31 can inhibit proliferation and increase apoptosis through inducing ER stress in colorectal cancer
Ke Xu, Bin Han, Yang Bai, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 3
Open Access | Times Cited: 80
Non-coding RNAs as therapeutic targets in cancer and its clinical application
Xuejiao Leng, Mengyuan Zhang, Yujing Xu, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 14, Iss. 7, pp. 100947-100947
Open Access | Times Cited: 12
Characterization and selective incorporation of small non-coding RNAs in non-small cell lung cancer extracellular vesicles
Chuang Li, Qin Fang, Fen Hu, et al.
Cell & Bioscience (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 68
MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN
Hui Lin, Zhiping Huang, Jiao Liu, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 68
Exosome-mediated miRNA delivery promotes liver cancer EMT and metastasis.
Qu Lin, Churen Zhou, Mingjun Bai, et al.
PubMed (2020) Vol. 12, Iss. 3, pp. 1080-1095
Closed Access | Times Cited: 67
Implication of the Hedgehog pathway in hepatocellular carcinoma
Carminia Maria Della Corte, Giuseppe Viscardi, Federica Papaccio, et al.
World Journal of Gastroenterology (2017) Vol. 23, Iss. 24, pp. 4330-4330
Open Access | Times Cited: 65
Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial–mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10
Yunxiuxiu Xu, Yu Lai, Linhui Cao, et al.
RNA Biology (2020) Vol. 18, Iss. 10, pp. 1408-1423
Open Access | Times Cited: 58
Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells
An-Fu Lee, Man‐Chin Chen, Chao‐Ju Chen, et al.
PLoS ONE (2017) Vol. 12, Iss. 7, pp. e0180383-e0180383
Open Access | Times Cited: 59
MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma
Weixun Chen, Zhanguo Zhang, Zeyang Ding, et al.
Oncotarget (2016) Vol. 7, Iss. 16, pp. 22674-22686
Open Access | Times Cited: 56
MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.
Min Wang, Junjie Zhang, Linlong Tong, et al.
PubMed (2015) Vol. 8, Iss. 11, pp. 14110-20
Closed Access | Times Cited: 55
miRNA-451a regulates RPE function through promoting mitochondrial function in proliferative diabetic retinopathy
Yan Shao, Lijie Dong, Yusuke Takahashi, et al.
AJP Endocrinology and Metabolism (2018) Vol. 316, Iss. 3, pp. E443-E452
Open Access | Times Cited: 54
Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics
Faisal S. Khan, Ijaz Ali, Ume Kalsoom Afridi, et al.
Hepatology International (2016) Vol. 11, Iss. 1, pp. 45-53
Closed Access | Times Cited: 53
Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib
Gianluigi Giannelli, Armando Santoro, Robin Kate Kelley, et al.
PLoS ONE (2020) Vol. 15, Iss. 3, pp. e0222259-e0222259
Open Access | Times Cited: 46
A comprehensive review on miR‐451: A promising cancer biomarker with therapeutic potential
Monireh Khordadmehr, Farinaz Jigari‐Asl, Hamed Ezzati, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 12, pp. 21716-21731
Closed Access | Times Cited: 45
The Bright and the Dark Side of TGF-β Signaling in Hepatocellular Carcinoma: Mechanisms, Dysregulation, and Therapeutic Implications
Medine Zeynep Gungor, Merve Uysal, Şerif Şentürk
Cancers (2022) Vol. 14, Iss. 4, pp. 940-940
Open Access | Times Cited: 25
MiR-30b-5p acts as a tumor suppressor, repressing cell proliferation and cell cycle in human hepatocellular carcinoma
Xian Qin, Jing Chen, Long Wu, et al.
Biomedicine & Pharmacotherapy (2017) Vol. 89, pp. 742-750
Closed Access | Times Cited: 48
Page 1 - Next Page

Scroll to top